Dermal Exposure to Vesicating Nettle Agent Phosgene Oxime: Clinically Relevant Biomarkers and Skin Injury Progression in Murine Models
The Journal of Pharmacology and Experimental Therapeutics · 2024
DOI: 10.1124/jpet.123.001718 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Pharmacology and Experimental Therapeutics, 2024. Verfasst von Dinesh G Goswami und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, College of Osteopathic Medicine (D.G.G., E.O.M.O., A.K.R., O.M., N.T.-S.) and Department of Biomedical Eng…. Hauptthemen laut MEDLINE: Phosgene, Mustard Gas, Chemical Warfare Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS.
Abstract (Originalsprache)
Phosgene oxime (CX), categorized as a vesicating chemical threat agent, causes effects that resemble an urticant or nettle agent. CX is an emerging potential threat agent that can be deployed alone or with other chemical threat agents to enhance their toxic effects. Studies on CX-induced skin toxicity, injury progression, and related biomarkers are largely unknown. To study the physiologic changes, skin clinical lesions and their progression, skin exposure of SKH-1 and C57BL/6 mice was carried out with vapor from 10 μl CX for 0.5-minute or 1.0-minute durations using a designed exposure system for consistent CX vapor exposure. One-minute exposure caused sharp (SKH-1) or sustained (C57BL/6) decrease in respiratory and heart rate, leading to mortality in both mouse strains. Both exposures caused immediate blanching, erythema with erythematous ring (wheel) and edema, and an increase in skin bifold thickness. Necrosis was also observed in the 0.5-minute CX exposure group. Both mouse strains showed comparative skin clinical lesions upon CX exposure; however, skin bifold thickness and erythema remained elevated up to 14 days postexposure in SKH-1 mice but not in C57BL/6 mice. Our data suggest that CX causes immediate changes in the physiologic parameters and gross skin lesions resembling urticaria, which could involve mast cell activation and intense systemic toxicity. This novel study recorded and compared the progression of skin injury to establish clinical biomarkers of CX dermal exposure in both the sexes of two murine strains relevant for skin and systemic injury studies and therapeutic target identification. SIGNIFICANCE STATEMENT: Phosgene oxime (CX), categorized as a vesicating agent, is considered as a potent chemical weapon and is of high military and terrorist threat interest since it produces rapid onset of severe injury as an urticant. However, biomarkers of clinical relevance related to its toxicity and injury progression are not studied. Data from this study provide useful clinical markers of CX skin toxicity in mouse models using a reliable CX exposure system for future mechanistic and efficacy studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, College of Osteopathic Medicine (D.G.G., E.O.M.O., A.K.R., O.M., N.T.-S.) and Department of Biomedical Engineering (S.K.S.), Michigan State University, East Lansing, Michigan;…
ORCID-Profile: Rajesh Agarwal, Neera Tewari-Singh
Förderung
- NIAMS NIH HHS
Zitieren
APA
Goswami, D. G., Singh, S. K., Okoyeocha, E. O. M., Roney, A. K., Madadgar, O., Tuttle, R., Sosna, W., Anantharam, P., Croutch, C. R., Agarwal, R., & Tewari-Singh, N. (2024). Dermal Exposure to Vesicating Nettle Agent Phosgene Oxime: Clinically Relevant Biomarkers and Skin Injury Progression in Murine Models. The Journal of Pharmacology and Experimental Therapeutics. https://doi.org/10.1124/jpet.123.001718
Vancouver
Goswami DG, Singh SK, Okoyeocha EOM, Roney AK, Madadgar O, Tuttle R, et al. Dermal Exposure to Vesicating Nettle Agent Phosgene Oxime: Clinically Relevant Biomarkers and Skin Injury Progression in Murine Models. The Journal of Pharmacology and Experimental Therapeutics. 2024. doi:10.1124/jpet.123.001718
BibTeX
@article{Goswami2024,
author = {Goswami, Dinesh G and Singh, Satyendra K and Okoyeocha, Ebenezar O M and Roney, Andrew K and Madadgar, Omid and Tuttle, Rick and Sosna, William and Anantharam, Poojya and Croutch, Claire R and Agarwal, Rajesh and Tewari-Singh, Neera},
title = {Dermal Exposure to Vesicating Nettle Agent Phosgene Oxime: Clinically Relevant Biomarkers and Skin Injury Progression in Murine Models},
journal = {The Journal of Pharmacology and Experimental Therapeutics},
year = {2024},
doi = {10.1124/jpet.123.001718}
}
EUVIMED